Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...
March 6, 2025 | Taylor Owen explains Justice Marie-Josée Hogue’s public inquiry into foreign interference that has identified disinformation as the most pressing danger to Canada’s democratic...
January 24, 2025 | The Supreme Court of Canada has agreed to grant permission to appeal in the Bill 21, Quebec’s controversial secularism law. The decision marks a significant development in the...
February 18, 2025 | Professor Vincent Rigby discussed the final report from the Public Inquiry into Canadian Foreign Interference, led by Justice Marie-Josée Hogue, released in late January after...
March 21, 2025 | Aengus Bridgman, director of the Media Ecosystem Observatory (MEO), explains what worries him about the information voters are getting online this election and how to make sure one...
RSS